Results 51 to 60 of about 53,326 (163)

Primary cutaneous anaplastic large-cell lymphoma in a patient with Hodgkin’s disease – case report

open access: yes, 2016
Introduction. Cutaneous anaplastic large cell lymphoma (C-ALCL) is one of the CD30+ lymphoproliferative disorders. Usually it has a mild course and does not require aggressive treatment. The prognosis in C-ALCL is good, with the 10-year survival rate
Dorota Kozłowska   +2 more
core   +1 more source

Progress in the diagnosis and treatment of mycosis fungoides with large cell transformation

open access: yesPifu-xingbing zhenliaoxue zazhi
Mycosis fungoides is a non-Hodgkin lymphoma originating from skin-resident memory helper T cells, representing the most common subtype of cutaneous T-cell lymphoma.
DANGZENG Zhuoma   +2 more
doaj   +1 more source

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options

open access: yes, 2012
Janet Y Li1, Steven Horwitz2, Alison Moskowitz2, Patricia L Myskowski3, Melissa Pulitzer4, Christiane Querfeld31College of Physicians and Surgeons, Columbia University, 2Department of Medicine, Lymphoma Service, 3Department of Medicine, Dermatology ...
Horwitz S   +5 more
core  

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma

open access: yes, 2008
David Kaminetzky1, Kenneth B Hymes21Division of Hematology/Oncology, New York University School of Medicine, New York, USA; 2New York University Cancer Institute, New York, USAAbstract: Cutaneous T-cell lymphoma/mycosis fungoides (CTCL/MF) is a rare ...
David Kaminetzky, Kenneth B Hymes
core  

T-cell receptor clonality analyses using nanopore sequencing for cutaneous T-cell lymphoma

open access: yes, 2023
Cieslak C, Rückert-Reed C, Busche T, et al. T-cell receptor clonality analyses using nanopore sequencing for cutaneous T-cell lymphoma. In: The Abstract from The EORTC Cutaneous Lymphoma Tumour Group Annual Meeting. European Journal of Cancer.
Stadler, Rudolf   +7 more
core   +1 more source

Multifocal cutaneous non-epitheliotropic B-cell lymphoma in a cat

open access: yesJournal of Feline Medicine and Surgery Open Reports, 2020
Case summary Skin tumours are the second-most common form of feline cancer after haematopoietic neoplasms and are often malignant. Cutaneous lymphoma is uncommon in cats and can be classified as epitheliotropic (typically of T-cell origin) or non ...
Fausto Quintavalla   +4 more
doaj   +1 more source

Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat

open access: yes, 2012
Sophia Rangwala, Madeleine Duvic, Chunlei ZhangDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAAbstract: Epigenetic modification with small molecule histone deacetylase inhibitors has been a promising new ...
Duvic M, Zhang CL, Rangwala S
core  

Indolent CD8+ lymphoid proliferation of the ear: A phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?

open access: yes, 2010
Recently, Petrella et al. described four patients with an unusual CD8+ lymphoid proliferation arising on the ear. These cases do not correspond clearly to any recognized category of cutaneous T-cell lymphoma (CTCL) described in the World Health ...
Beltraminelli, Helmut   +2 more
core   +1 more source

Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization [PDF]

open access: yes, 2010
Extranodal natural killer/T-cell (ENK/T) lymphoma is a rare neoplasm, subcategorized into ENKITnasal ENK/T-N) and ENK/T-nasal type (ENK/T-NT) lymphomas.
E. Berti   +7 more
core  

Specific nail alterations in cutaneous T-cell lymphoma: successful treatment with topical mechlorethamine

open access: yes, 2010
Cutaneous T-cell lymphoma can be associated with clinically significant nail alterations, the presentation of which can be protean and misleading. To date, only a few reports have demonstrated direct specific tumor infiltration of the nail bed, while ...
Helmut Beltraminelli   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy